Abstract:Cardiomyocyte-restricted overexpression of FK506-binding protein 12 transgenic (αMyHC-FKBP12) mice develop spontaneous atrial fibrillation (AF). The aim of the present study is to explore the mechanisms underlying the occurrence of AF in αMyHC-FKBP12 mice. Spontaneous AF was documented by telemetry in vivo and Langendorff-perfused hearts of αMyHC-FKBP12 and littermate control mice in vitro. Atrial conduction velocity was evaluated by optical mapping. The patch-clamp technique was applied to determine the potentially altered electrophysiology in atrial myocytes. Channel protein expression levels were evaluated by Western blot analyses. Spontaneous AF was recorded in four of seven αMyHC-FKBP12 mice but in none of eight nontransgenic (NTG) controls. Atrial conduction velocity was significantly reduced in αMyHC-FKBP12 hearts compared with NTG hearts. Interestingly, the mean action potential duration at 50% but not 90% was significantly prolonged in αMyHC-FKBP12 atrial myocytes compared with their NTG counterparts. Consistent with decreased conduction velocity, average peak Na+ current ( INa) density was dramatically reduced and the INa inactivation curve was shifted by approximately +7 mV in αMyHC-FKBP12 atrial myocytes, whereas the activation and recovery curves were unaltered. The Nav1.5 expression level was significantly reduced in αMyHC-FKBP12 atria. Furthermore, we found increases in atrial Cav1.2 protein levels and peak L-type Ca2+ current density and increased levels of fibrosis in αMyHC-FKBP12 atria. In summary, cardiomyocyte-restricted overexpression of FKBP12 reduces the atrial Nav1.5 expression level and mean peak INa, which is associated with increased peak L-type Ca2+ current and interstitial fibrosis in atria. The combined electrophysiological and structural changes facilitated the development of local conduction block and altered action potential duration and spontaneous AF. NEW & NOTEWORTHY This study addresses a long-standing riddle regarding the role of FK506-binding protein 12 in cardiac physiology. The work provides further evidence that FK506-binding protein 12 is a critical component for regulating voltage-gated sodium current and in so doing has an important role in arrhythmogenic physiology, such as atrial fibrillation.

Transgenic analysis of the role of FKBP12.6 in cardiac function and intracellular calcium release

FKBP12.6 Protects Heart from AngII-induced Hypertrophy Through Inhibiting Ca2+ /Calmodulin-Mediated Signalling Pathways in Vivo and in Vitro.

FKBP12 is a critical regulator of the heart rhythm and the cardiac voltage-gated sodium current in mice

Oestrogen Protects FKBP12.6 Null Mice from Cardiac Hypertrophy.

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene

Atrial Fibrillation and Electrophysiology in Transgenic Mice with Cardiac-Restricted Overexpression of FKBP12.

Fkbp12.6 and Cadpr Regulation of Ca2+ Release in Smooth Muscle Cells

Programmed Exercise Attenuates Familial Hypertrophic Cardiomyopathy in Transgenic E22K Mice via Inhibition of PKC-α/NFAT Pathway

Consequences of Cardiac Myocyte-Specific Ablation of KATPchannels in Transgenic Mice Expressing Dominant Negative Kir6 Subunits

Casein Kinase-2 Interacting Protein-1 Regulates Physiological Cardiac Hypertrophy via Inhibition of Histone Deacetylase 4 Phosphorylation

Sensitized Signalling Between L-type Ca2+channels and Ryanodine Receptors in the Absence or Inhibition of FKBP12.6 in Cardiomyocytes

Identification of RyR2-PBmice and the Effects of Transposon Insertional Mutagenesis of the RyR2 Gene on Cardiac Function in Mice.

Programmed Exercise Attenuates Familial Hypertrophic Cardiomyopathy in Transgenic E22K Mice <i>via</i> Inhibition of PKC-/NFAT Pathway

FKBP Binding Characteristics of Cardiac Microsomes from Diverse Vertebrates

Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.

Role of FKBP12.6 in Hypoxia- and Norepinephrine-Induced Ca2+ Release and Contraction in Pulmonary Artery Myocytes

Dissociation of FKBP12.6 from ryanodine receptor type 2 is regulated by cyclic ADP-ribose but not β-adrenergic stimulation in mouse cardiomyocytes

Cardiac Contractility, Motor Function, and Cross‐bridge Kinetics in N47K‐RLC Mutant Mice

Abstract 13431: Gain-of-Function Mutations in RNA Binding Motif 20 Result in Cardiac Remodelling and Pathogenesis in Mice

Relationship between HSPA1A-regulated gene expression and alternative splicing in mouse cardiomyocytes and cardiac hypertrophy

The effects of conditional loss of myosin binding protein H-like on cardiac function.